Product Update
Is Basepaws Still in Business? (2026 Update)
Is Basepaws from Shark Tank still around in 2026? The deal it made, the sharks who invested, and where to buy Basepaws today.
As an Amazon Associate I earn from qualifying purchases.
Basepaws pitched cat DNA testing kits in Season 10, and the company did not just survive, it got bought by one of the largest animal health corporations on earth. Anna Skaya's genetics startup is now part of Zoetis, and the acquisition is one of the biggest exits in Shark Tank history for a pet products company.
The Short Answer
Yes, Basepaws is still in business and, if anything, bigger than it was on the show. The company was acquired by animal health giant Zoetis in June 2022 for a reported price of more than 50 million dollars.
Basepaws products are sold direct through the company's own website, offering breed and health DNA tests, whole genome sequencing, oral health tests, and trait reports, now expanded to cover dogs as well as the cats the company started with. It is not sold on Amazon.
The Shark Tank Pitch
Anna Skaya pitched in Season 10, Episode 21, bringing an at-home DNA testing kit for cats that could screen for breed ancestry and genetic health markers, built on a genomics database she and her team had assembled from feline samples.
She asked for 250,000 dollars for 5 percent equity, a 5 million dollar valuation, aiming to bring genetic testing to a pet category that had mostly been built around dogs up to that point. Basepaws later returned to the Shark Tank franchise for a follow-up appearance highlighting its growth, an update segment the show occasionally runs for standout companies from earlier seasons, which is itself a signal of how far the business had come since its original pitch.
The Deal That Got Done
Kevin O'Leary and Robert Herjavec joined forces and offered 250,000 dollars for 10 percent equity, doubling the equity stake from what Anna had originally proposed in exchange for the same amount of cash. Herjavec's background funding consumer tech and data-driven products made him a natural fit for a genomics startup, while O'Leary's involvement added the kind of scrutiny on unit economics that pet DNA testing, a business built on repeat lab processing costs per kit, would need to survive past a single hot launch season.
That dilution turned out to be a small price for what came next. Revenue reportedly jumped from around 200,000 dollars to 3.5 million dollars in 2022 alone, helped by new products like a cat dental health test and a COVID-19 test for pets that launched during the pandemic.
Basepaws net worth in 2026
The clearest verified figure here is the acquisition price. Zoetis, a publicly traded animal health company, acquired Basepaws in June 2022 for a reported sum of over 50 million dollars, a number that has circulated across Shark Tank tracking sites and pet industry press covering the deal. That is a real, sourced acquisition figure, not a speculative estimate, though the exact final terms were not fully disclosed by either company.
Anna Skaya reportedly stayed on to run operations after the sale, with the team still based in Santa Monica, which suggests Zoetis valued the founding team's continued involvement rather than folding the brand and walking away. That kind of retention after an acquisition tends to track with a genuine strategic buy rather than an asset stripping. Zoetis is a Fortune 500 animal health company with products spanning livestock and companion animals worldwide, so folding a genetics startup into that structure gave Basepaws access to veterinary distribution channels and research resources a standalone startup would take years to build on its own.
Where Things Stand Now
Here is the recap. Basepaws pitched in Season 10 asking for 250,000 dollars at 5 percent, and closed with Kevin O'Leary and Robert Herjavec at 10 percent instead.
Revenue grew from roughly 200,000 dollars to 3.5 million dollars in a single year following new product launches, then the company expanded into dog DNA testing and vet-focused microbiome tools before Zoetis bought the whole operation in June 2022 for a reported 50 million dollars plus.
So yes, Basepaws made it, and made it big. The brand is alive, expanded past cats into dogs, and now backed by one of the largest animal health companies in the world instead of a small startup team, a rare exit outcome that puts it near the top of every Shark Tank pet products company by dollar value.
Where to buy Basepaws
Still selling as of January 14, 2026. Check today's price and availability.
Affiliate link — we may earn a commission at no extra cost to you.
See the full Basepaws deal breakdown and term sheet →
